AI-guided ablation for hard-to-treat atrial fibrillation
Part of Heart & circulation clinical trials.
This trial uses an artificial intelligence system (vMap) to find and target abnormal electrical signals outside the pulmonary veins that may be driving atrial fibrillation (AF). The goal is to improve ablation results for people with persistent or recurrent AF.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with persistent atrial fibrillation (AF) that has lasted less than one year, or you have recurrent AF.
- You are at least 22 years old.
- You are scheduled to have a catheter ablation procedure for AF at your doctor's recommendation.
- You have a recent 12-lead electrocardiogram (ECG) of your AF recorded on a compatible system (e.g., Bard, Boston Scientific, GE, CardioCard).
- You have not had a prior procedure that isolated all four pulmonary veins (PVs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a special heart-mapping device during ablation (a procedure to fix irregular heartbeats) can improve outcomes for people with persistent atrial fibrillation and an enlarged left heart chamber.
This trial tests a new way to map the heart's electrical signals to help doctors better target and treat atrial fibrillation (an irregular heartbeat). If you're having a procedure to treat AF, this study may help improve the success of your treatment.
This trial uses a special body-surface mapping technique to guide personalized ablation for persistent atrial fibrillation (afib). It aims to improve outcomes for people with an enlarged left atrium who have not had prior ablation.
This study tests a new type of ablation (pulsed field ablation) for people with atrial fibrillation who haven't gotten enough relief from medication alone. It aims to see if isolating the superior vena cava along with the pulmonary veins is safe and effective.
This study tests whether an AI software can help doctors identify which people with persistent atrial fibrillation might need more than just a standard ablation procedure. The software analyzes heart signals during the ablation to guide treatment, potentially improving outcomes for people whose condition is more complex.
This trial tests whether an artificial intelligence (AI) system can help choose the best patients for a procedure called catheter ablation for atrial fibrillation (AF). It may improve which people benefit most while keeping safety in mind.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.